CANY
PRCT icon

Caxton Associates (New York)’s Procept Biorobotics PRCT Stock Holding History

Caxton Associates (New York)’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,033
Closed -$430K – 626
2024
Q2 		$430K Buy
+7,033
New +$430K 0.01% 352